ketanserin has been researched along with Thrombocytopathy in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egermayer, P | 1 |
Town, GI | 1 |
Peacock, AJ | 1 |
Herve, P | 1 |
Drouet, L | 1 |
Dosquet, C | 1 |
Launay, JM | 1 |
Rain, B | 1 |
Simonneau, G | 1 |
Caen, J | 1 |
Duroux, P | 1 |
1 review available for ketanserin and Thrombocytopathy
Article | Year |
---|---|
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
Topics: Blood Platelet Disorders; Collagen Diseases; Humans; Hypertension, Portal; Hypertension, Pulmonary; | 1999 |
1 other study available for ketanserin and Thrombocytopathy
Article | Year |
---|---|
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
Topics: Blood Platelet Disorders; Blood Platelets; Blood Pressure; Humans; Hypertension, Pulmonary; Ketanser | 1990 |